**Chapter 5**

*Rhinosinusitis*

Invited review

bacteria. Transfusion. 1996;**36**:362-374.

[53] Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the *Escherichia coli* phylogenetic group. Applied and Environmental Microbiology. 2000;**66**:4555-4558

[54] Adamus-Białek W, Wojtasik A, Majchrzak M, Sosnowski M, Parniewski P. (CGG)4 based PCR as a novel tool for discrimination of uropathogenic *Escherichia coli* strains: Comparison with enterobacterial repetitive intergenic consensus PCR. Journal of Clinical Microbiology. 2009;**47**:3937-3944

[55] Johnson JR, Brown JJ, Carlino UB, Russo TA. Colonization with and acquisition of uropathogenic *Escherichia coli* as revealed by polymerase chain reaction-based detection. The Journal of Infectious Diseases. 1998;**177**:1120-1124

[56] Krawczyk B, Śledzińska A, Piekarska A, Hellmann A, Kur J. Recurrent bowel-blood translocations of *Escherichia coli w*ith the unique virulence characteristics over three-year period in the patient with acute myeloid leukaemia—Case report. Journal of Applied Genetics. 2017;**58**(3):415-418

[57] Nowak-Zaleska A, Wieczór M, Czub J, Nierzwicki Ł, Kotłowski R, Mikucka A, et al. Correlation between the number of Pro-Ala repeats in the EmrA homologue of Acinetobacter baumannii and resistance to netilmicin, tobramycin, imipenem and ceftazidime.

Journal of Global Antimicrobial Resistance. 2016;**7**:145-149

2016;**5**(1):1

[58] Mobley HLT, Alteri CJ. Development of a vaccine against *Escherichia coli* urinary tract infections. Pathogens.

[47] Nowicki B, Nowicki S, Selvarangan

R. Family of *Escherichia coli* Dr adhesins: Decay-accelerating factor receptor recognition and invasiveness. The Journal of Infectious Diseases.

2001;**183**(Suppl 1):S24-S27

Diseases. 2000;**181**:261-272

[49] Krawczyk B, Śledzińska A, Szemiako K, Samet A, Nowicki B, Kur J. Characterisation of *Escherichia* 

*coli* isolates from the blood of haematological adult patients with bacteraemia: Translocation from gut to blood requires the cooperation of multiple virulence factors. European Journal of Clinical Microbiology and Infectious Diseases.

[50] Szemiako K, Krawczyk B, Samet A, Śledzińska A, Nowicki B, Nowicki S, et al. A subset of two adherence systems, acute pro-inflammatory *pap* genes and invasion coding *dra*, *fim*, or *sfa*, increases the risk of *Escherichia coli* translocation to the bloodstream.

Microbiology and Infectious Diseases.

[51] Le Bouguenec C, Archambaud M, Labigne A. Rapid and specific detection

[52] Krawczyk B, Samet A, Leibner J, Śledzińska A, Kur J. Evaluation of a PCR melting profile technique for bacterial strain differentiation. Journal of Clinical Microbiology. 2006;**44**:2327-2332

of the *pap*, *afa*, and *sfa* adhesin encoding operons in uropathogenic *Escherichia coli* strains by polymerase chain reaction. Journal of Clinical Microbiology. 1992;**30**:1189-1193

European Journal of Clinical

2013;**32**(12):1579-1582

2015;**34**(6):1135-1143

[48] Johnson JR, Stell AL. Extended virulence genotypes of *Escherichia coli* strains from patients with urosepsis in relation to phylogeny and host compromise. The Journal of Infectious

**56**
